KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues. KLISBio is significantly contributing to healthcare innovation, disrupting the restorative surgical market in several clinical indications by bringing innovation via a truly versatile biocompatible material, robust scientific and chemical expertise and operational excellence.